SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " bio " 2,884 found 🔀 AI-powered Shuffle
Marine biobanks: the science of 'stopping time' for an ecosystem under pressure
In labs around the world, the ocean is being kept in jars. Some of it is alive, bubbling in flasks, while some lies frozen in liquid nitrogen. These marine biobanks are collections of coral cells, algae,…
Pro-Israel influencers criticize Vance, but evangelicals remain open to him
Despite attacks from some conservatives, a heavily pro-Israel crowd still has warm words for Vance, with many saying they could pick him as the party’s nominee.
Scientists infected a 'vagina on a chip' with gonorrhea — then cured it with a new antibiotic found by AI
To sift through 6 million molecules in pursuit of new gonorrhea treatments, researchers trained AI to select the best drug candidate and then tested it in a "vagina on a chip."
Why Do Deadly Viruses Spare Mosquitoes? Science Has an Answer
Mosquitoes carry some of the world's deadliest viruses, biting victim after victim for their entire lives without ever getting sick themselves. Scientists have long suspected a biological explanation,...
Scientists stunned by signs of ancient life in a place no one expected
Scientists exploring ancient seafloor rocks in Morocco discovered mysterious wrinkle patterns where they were never expected to occur. These structures are normally linked to microbial mats in shallow, sunlit waters, yet the rocks formed hundreds of feet below the surface in darkness. Evidence indicates that chemosynthetic microbes created the wrinkles, revealing that deep-ocean microbial ecosystems may have been more widespread than previously thought.
AI Assistant Tool QED Scores bioRxiv Preprint Quality
QED, an AI assistant tool, evaluates the originality and validity of bioRxiv preprints, assigning them QED Scores. Researchers report that its rankings often align with expert opinion.
Priscilla Chan on science, disease prevention and the future of medicine
CNBC's Becky Quick sits down for a conversation with Dr. Priscilla Chan, co-founder of Biohub, at Aspen Ideas: Health.
Democratic socialists’ battleground test: From the Politics Desk
Plus, Pete Buttigieg is back on the campaign trail. And digging into Michael Whatley’s bio in the North Carolina Senate race.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence
Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life science value chain by expanding its presence in high-growth, next-generation life-sci markets with Bio-Techne’s tools, analytical technologies, and consumables.
Bio-Techne, a Minneapolis life sciences firm with 500,000 products, to be sold to German company for $11.3 billion
UT Health San Antonio identifies the first potential probiotic treatment for lupus
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 25, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link between a bacterium in the gut microbiome, or ecosystem, and lupus, which could lead to more effective […]
Finding Strength Through Sports While Living with Phenylketonuria
Episode 3 explores how teens with PKU balance the demands and realities of athletics while managing this metabolic condition.
Rubio’s spin on the Iran MOU sounds different from Trump and Vance
For more than a week, America’s top diplomat was conspicuously quiet about something that would have seemed very much in his wheelhouse: a nascent agreement with Iran. But now Secretary of State Marco Rubio is speaking.
Merck KGaA bolsters life sciences business with $11.3B Bio-Techne buy
The deal comes a matter of weeks after Kai Beckmann was promoted to CEO at Merck and signalled his intent to broaden the company's scope for M&A.
Poor metabolic health can age the brain even in young people, finds new large-scale study
Two people of very different ages can have a similar level of biological aging in their brains. Such an occurrence is possible because aging and metabolic health follow two distinct pathways that influence ...
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
Regenerative Agriculture and Population Health
Regenerative agriculture can enhance food quality and reduce harmful exposures through improved soil biology, biodiversity, and ecosystem health, yielding downstream benefits for agriculture, food systems, and human health. It may improve profitability through greater land resilience and lower input costs and may deliver benefits to farms, farmers, communities, and the broader environment. More research is warranted to understand the full range of potential health benefits of regenerative agriculture.
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Germany's Merck to buy Bio-Techne for $11.3 billion
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
Germany's Merck to buy Bio-Techne for $73 per share
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the German science and healthcare firm said in a statement on Thursday.
Germany’s Merck to Buy Bio-Techne for $11 Billion
Merck KGaA offered $73 a share in cash to buy Bio-Techne, representing a 24% premium to the U.S. lab-tools supplier’s closing price Wednesday.
Rubio reassures Gulf allies as US-Iran talks advance
Tehran has already portrayed the deal as a victory
The history behind the Marcus Alert System
Marcus-David Peters was a 24-year-old high school biology teacher at Essex High School when he died.
Student From Des Plaines Wins National Science Foundation Award
Elmhurst University biochemistry major Hannah Cardenas, of Des Plaines, recently received a National Science Foundation Research Experiences for Undergraduates (NSF REU) award to participate in a 10-week summer research internship at the University of Texas at Dallas.
The biotech founder asking why good science gets stuck
As an undergraduate, Alinta Furnell led student societies, pitched startup ideas and built biotechnology ventures. Now, the UNSW alumna is investigating one of innovation’s biggest challenges – why so many scientific breakthroughs never make it beyond the lab.
Mercy Helps Position St. Louis as Global Gateway for Healthcare Innovation
Mercy continues to bring innovative thought leadership to the communities it serves and beyond. Dr. Damon Broyles, Mercy vice president of clinical innovation, informatics and precision medicine, recently shared insights and helped attract new companies to St. Louis’ nationally recognized healthcare industry as part of BioSTL.
Scientists design 'tunable' biomolecules to probe how sugars behave
Sugars are not just a source of energy—they also play a crucial role in how cells communicate, how proteins interact and how materials behave in medicine and industry. But studying these processes is ...
Giant viruses discovered on Greenland ice sheet may slow glacial melting - Futura-Sciences
Giant viruses defy microbiological norms Lead author Laura Perini and her team at the Department of Environmental Science at Aarhus University identified the microorganisms during a field survey of Arctic ice. Measuring up to 2.5 micrometers in length, these viral specimens are roughly 125 times larger than conventional viral strains....
Top supplements Americans use are shifting from multivitamins to targeted health fixes
Dietary supplements are an excellent way to fill gaps in our nutritional requirements. From vitamins and macronutrients to gut-health probiotics, dietary supplements have helped people address deficiencies. ...
QED Science Launches AI Infrastructure for Scientific Validation
Recognizes The 1% After Blind Evaluation of 57,455 Scientific PreprintsTEL AVIV, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- QED Science, a science validity engine and modern infrastructure for researchers, funders, institutions and life science organizations today launched The 1%, the top 574 life science preprints. The company anonymously scored 57,455 bioRxiv preprints submitted between May 2025 and April 2026 for originality and validity. The ranking is powered by QED Score, QED Science’s vali
This startup is using AI to close gaps in women’s healthcare
Xella Health’s precision health platform combines biomarker testing, clinical guidance, and AI analysis to help women get earlier answers about hard-to-diagnose conditions.
Venetian exec talks luxury meeting space and the future of conventions
Venetian Chief Sales Officer Tony Yousfi shares what drove renovations at the Convention and Expo Center and the innovations he believes will define the next era of conventions at the Strip resort.
The universe may be hiding conscious minds stranger than we can imagine
What if consciousness isn’t limited to brains like ours? Philosophers Eric Schwitzgebel and Jeremy Pober argue that consciousness could arise in many different forms of life, even in beings built from radically different materials than those found on Earth. Drawing on the vastness of the universe and the likely existence of countless alien civilizations, they suggest it would be surprisingly Earth-centric to assume that only Earth-like biology can support conscious experience.
A staunch voice in support of science
Jeff Coller, a pioneering RNA biologist, has spent the past year vehemently advocating for the lifesaving promise of research in the face of federal cuts
France confirms first Ebola case in doctor returning from DR Congo
The patient is in isolation, following strict biosafety protocols to prevent risk of spread in France.
Flagship Pioneering and Lean Business Services Company Announce Collaboration to Advance Healthcare Innovation and AI-Enabled Biomedical Research in Saudi Arabia
/PRNewswire/ -- Flagship Pioneering, the scientific innovation company behind Moderna, Generate Biomedicines, and more than 100 other life sciences ventures,...
From collagen to creatine, shop 10 Amazon supplement deals worth buying
Discover the best Amazon Prime Day supplement deals, including discounts on fish oil, collagen, probiotics and more—save up to 33% today.
Why the Madonna biopic starring Julia Garner isn't happening after all
Through the process of writing the script, Madonna was bitten by the memoir bug, and she channeled that energy into her forthcoming album "Confessions on a Dance Floor: Part II," which drops July 3.
Science Will Not Save the Abortion Pill : The Hastings Center for Bioethics
The facts are not enough. In addition to using evidence, people who support the legal right to abortion must make the moral case for it.
Nvidia Unveils Science Reasoning AI Suite with BioNeMo Agent Toolkit
The toolkit has applications across generative chemistry, genomic analysis, protein design, and biomarker discovery.
A heartfelt and emotional ‘Tick, Tick... Boom!’ from Triune Entertainment
Jonathan Larson’s autobiographical musical is performed with a wonderful blend of harmonies in the ensemble numbers.
Brooklyn College Names New Dean for the Murray Koppelman School of Business
Shalei V. K. Simms, Ph.D., appointed to lead Brooklyn’s only AACSB-accredited business school.
Offworld Space Biology: Setting Up The Life Science Glovebox
Bioengineering cartilage tissues and manufacturing advanced materials kicked off the week aboard the International Space Station
Master’s Program Revamped to Address Informatics Needs
The Master of Science in Biomedical Informatics program — previously known as the Master of Science in Health and Biomedical Informatics — will launch in the fall offering two tracks: one in bioinformatics and another in health informatics.
Pivot Fellow Natasha Blitvic Brings Math to Marine Microbiology
Pivot Fellow Natasha Blitvic Brings Math to Marine Microbiology on Simons Foundation
9 Fruits With the Most Prebiotics For Better Gut Health
Prebiotics are a type of fiber that feeds the good bacteria in your gut, supporting better digestion and overall health. These fruits are a tasty way to get more prebiotics.
Behind this “ordinary snake,” scientists stunned by a hidden new species - Futura-Sciences
A Mysterious Snake Revealed Researchers from the Chengdu Institute of Biology, partnering with the Giant Panda National Park, have officially described a new species of tree viper: Trimeresurus lii, affectionately dubbed the Huaxi green viper. The discovery was made in early 2025 and published in the open-access journal Zoosystematics and...
Build an AI Scientist for Life Science Discovery with NVIDIA BioNeMo Agent Toolkit
AI scientists are emerging as a new interface for scientific computing. These agents can read papers, write code, generate hypotheses, call APIs, inspect files, and iterate on results. But science isn’…
Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer
Dr. Martini brings extensive industry, government, and academic expertise to KIFFIK Biomedical, strengthening translational science capabilities as the company advances its K-EXP™ platform and expands access to interstitial fluid (ISF)
Hidden bird species discovered in Japan after DNA reveals a stunning secret
A bird long thought to be a single rare species in Japan has turned out to be two. Scientists discovered that the elusive Ijima’s Leaf Warbler and a newly identified Tokara Leaf Warbler look almost identical, but their DNA and songs reveal they are distinct species. The finding marks Japan’s first new bird species discovery in more than 40 years and highlights how modern genetic tools are uncovering hidden biodiversity that would otherwise go unnoticed.
The tea in your kombucha changes more than just the taste
Scientists discovered that kombucha’s flavor, chemistry, and antioxidant activity vary dramatically depending on the tea used to make it. Green and oolong tea kombuchas emerged as the most biologically active, while fermentation transformed each tea into a distinctly different beverage.
From soil to gut: why your gut health depends on the world around you
On this World Microbiome Day, we explore the One Health perspective: the idea that human, animal, and environmental health are not separate concerns but expressions of the same interconnected system.
8 Probiotic Foods Recommended by a Nutritionist to Support Gut Health
A nutritionist and a registered dietitian share which foods help populate good bacteria in your gut.
New framework renders AI trustworthy for cancer subtyping
The framework, reported in Nature Biomedical Engineering, is broadly adaptable as a wrapper for digital pathology AI systems.
Ending birthright citizenship could be a public health disaster
If the Supreme Court upholds the executive order ending birthright citizenship, it could “have stark consequences at the intersection of bioethics and public health.”
Experts on history, politics reflect on U.S. 250th birthday milestone
As our nation’s celebration of its 250th birthday approaches, experts in history and political science at Virginia Tech can provide perspectives on how far the United States of America has advanced since its founding and the issues that will influence where it goes next.
Fermented food microbiome: influence on oral and gut microbiota, and human health
Nature Reviews Microbiology - The bioactive compounds and microbial consortia contained in plant-based fermented foods support oral and gut microbiota, host immune function and metabolic...
Watch Novonesis on Business Strategy
Ester Baiget, CEO of Danish biosolutions company Novonesis, discusses the firm's China business and growth strategy. She speaks with Minmin Low from the sidelines of the World Economic Forum's Annual Meeting of the New Champions in Dalian.
Health Brief: FDA signals reset in drug reviews
Plus: The data behind China’s biotech surge
We must support 'strange' science, RNA biologist Jeff Coller writes in The New York Times
Without federal funding, American researchers can't chase scientific questions that may lead to lifesaving cures, Hopkins RNA biologist Jeff Coller writes in 'The New York Times'
Federal health agencies unveil plan to speed up phase 1 clinical trials by 6 to 12 months
As the biotech world flocks to San Diego today for the BIO International Convention, the Department of Health and Human Services has provided plenty of conversation fodder with the announcement of | As the biotech world flocks to San Diego today for the BIO International Convention, the Department of Health and Human Services has provided plenty of conversation fodder with the announcement of a series of efforts to regain ground on China’s surging early-stage clinical development capabilities.
Moment of Science: “Antscan” project uses particle accelerator to map small insects in 3-D
It's the world of ants like you've never seen it before! Dan Smith shows how biology and particle physics are teaming up in the "Antscan" project. 🐜
Building a Roadmap for Hubble Science into the 2030s: Revealing Atmospheric Structure and Evolution in Substellar Worlds Using HST
Substellar objects occupy a unique place in our universe
University of Hawaiʻi researchers awarded $12M grant to advance AI, data science in medicine
The funding will be dedicated to accelerating biomedical discoveries through AI and data science to benefit people in Hawaiʻi and the Pacific region, and worldwide.
A common vitamin could help fight one of the deadliest brain cancers
A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive brain cancer. Scientists found that niacin may help revive immune cells that tumors shut down, allowing them to attack cancer more effectively. Early results have been promising, with patients showing significantly better progression-free survival than expected.
KSU master’s graduates benefit from NIH-funded bridge program
Recent Kennesaw State University graduate April Ford engaged in a program designed to help master’s students in the College of Science and Mathematics gain the experience they needed to pursue doctoral degrees elsewhere. She’ll stand as an example of the Peach State Bridges to the Doctorate program’s effectiveness, having earned her Master of Science in Integrative Biology (MSIB) and acceptance into a Ph.D. program. Ford, Jojo Croffie, and Lindsey Knight all earned their MSIB degrees, and thanks to enrichment through the Peach State Bridges to the Doctorate program, each will start a Ph.D. in the fall.
8 things to know about the gut microbiome and keeping yours healthy
Wellness influencers often talk about fixing a broken gut microbiome. And marketers sell tests and supplements to fix your gut health. Here's what what the evidence really shows about gut health.
Science Over Tradition: Plymouth South Middle Schoolers Advocate for Later School Start Times
PLYMOUTH - June 15, 2026 - In a powerful demonstration of student advocacy, a delegation of eighth-grade students from Plymouth South Middle School presented compelling, science-based research to the School Committee, urging district leadership to push back school start times to improve adolescent mental health, well-being, and academic performance. The presentation sparked immediate commitment from the administration to formally evaluate the district’s schedule over the coming school year. Subscribe The Full Story The final in-person meeting of the academic year opened with a celebratory outdoor ceremony honoring dozens of elementary, middle, and high school student artists whose work was chosen for the biannual Central Office Artwork Awards. However, the evening’s primary policy focus quickly shifted to student-led civic action when eighth graders Sophia Scarini, Skye Togun, Leah Mansfield, James Moore, Avery Mahan and Lily Simpson took the podium. The students revealed that their presentation was the culmination of a year-long civics project involving local community assessments, interviews with former officials, and extensive literary analysis. The research sharply highlighted the biological mismatch between adolescent sleep patterns and current school schedules. Under the district’s current framework, Plymouth High Schools open at 7:20 a.m., Middle Schools at 8:12 a.m., and Elementary Schools at 9:05 a.m.. “The high school start times directly contradict students’ natural sleep patterns,” student Leah Mansfield explained, noting that the teenage brain does not naturally produce melatonin until around 11:00 p.m.. The student presentation underscored a harrowing correlation between sleep deprivation and severe mental health struggles, citing data that adolescents with insomnia are ten times more likely to develop depression. Conversely, data shows that just one additional hour of sleep results in a 28% reduction in students reporting feelings of depression or sadness.
Trump’s Iran agreement embraces sanctions relief, a policy he and his team once denounced
For years, President Donald Trump, Secretary of State Marco Rubio and Vice President JD Vance argued against deals that provided financial concessions to Iran, saying that giving the regime money fuels terror. But now the agreement they’ve reached to end the war with Tehran is poised to hand the regime billions.
What Would Faster Sequencing Mean for Your Research?
In this Teach Me In 10, Dr. Nick Scales, Technical Sequencing Specialist at Plasmidsaurus, discusses how Plasmidsaurus help researchers gain deeper biological insights while reducing common workflow bottlenecks.
ESA Exploration Science Workshop 2026 – Early Career Researchers Abstract Submissions
The European Space Agency is pleased to announce a Call for Abstracts for Early Career Researchers to submit abstracts to the ESA Exploration Science Workshop 2026
AMD Ryzen 9 9900X owner reports CPU failure with package bump while using early 2026 BIOS
A Ryzen 9 9900X owner has reported a sudden CPU failure on the MSI MAG X870E Tomahawk WiFi motherboard.
The surprising science of how fatherhood changes the brain
Recent studies suggest that, like mothers, fathers may undergo a profound shift in their biology and brains in preparation for and response to the responsibilities of parenthood.
Ezekiel Emanuel: My father lived into his 90s. He understood something many successful men miss
The wellness industry wants you obsessing over biomarkers and supplements. One physician's life offers a simpler—and more effective—blueprint for aging.
Bigger, fewer, tougher: the new era of China-US biotech partnerships
China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.
UH researchers awarded $12M grant to advance AI, data science in medicine | University of Hawaiʻi System News
New center will support innovative biomedical research, develop future scientific leaders, and expand research infrastructure in Hawaiʻi.
Major review finds vaping likely causes lung and oral cancer
Researchers have concluded that nicotine vapes are likely to cause lung and oral cancers, based on evidence ranging from human biomarkers to animal and laboratory studies. The findings challenge the idea that vaping is a harmless alternative to smoking and suggest health risks may be emerging much sooner than many expected.
Netherlands vs Sweden Extended Highlights
Check out the full game highlights between Netherlands and Sweden in the 2026 FIFA World Cup™. Announced by Darren Fletcher and Owen Hargreaves.
Israel Pennerman: From The Bahamas to Biomedical Science, A Journey of Discovery & Purpose
Fall 2025 Graduate | Public Health Science For Israel Pennerman, pursuing a degree in Public Health Science was never simply about earning a diploma. It was about gaining the knowledge and skills needed to address health challenges facing communities around the world. Originally from Nassau, The Bahamas, Pennerman arrived at Saint Augustine’s University with a […]
Unusual creatures are more appealing: What guppies teach us about evolution
Spanish biologist Ignacio Paulin became fascinated by the behavior of these fish, in a project that could now disappear due to budget cuts by the Trump administration
Amazon no longer releasing Sam Altman biopic 'Artificial' starring Andrew Garfield
Amazon announced that it will no longer release Luca Guadagnino's Sam Altman biopic 'Artificial' starring Andrew Garfield. The news comes four months after OpenAI announced a strategic partnership with Amazon.
The science of 'Dad Brain' and how fatherhood changes men
While most scientific research has focused on men, when it comes to parenthood, it's all about mothers. But new research shows that men undergo profound changes biologically and psychologically when they become fathers. Horizons moderator William Brangham explores the surprising science of "Dad Brain" with Darby Saxbe.
Two W.Va. health departments are offering a Lyme disease preventative antibiotic
Kanawha-Charleston, Fayette County health departments offer antibiotic to fight Lyme disease
Faecal transplant makes the brains of old mice act young again
Older mice that received a faecal microbiome transplant from younger animals went on to have improved brain plasticity, which meant their brains could overcome a neurological condition that is typically successfully treated only in childhood
K-Beauty's New Frontier: Microbiome Science Hits U.S. Retail Shelves
South Korean brand Lactomedi’s nationwide CVS launch signals a major shift in feminine care, blending K-Beauty innovation with advanced microbiome science.
Fossils challenge assumptions on how animals adapted to land
Scientists have long posited the earliest water animals to transition to land had amphibious tadpole features, going through a metamorphosis akin to that of today's frogs.That's not what we would expe...
This giant tropical fruit could help reverse gum disease damage
A new biomaterial made from jackfruit latex, pomegranate peel, and simvastatin could transform the treatment of severe gum disease. Early tests suggest it not only combats infection and inflammation but may also help rebuild lost bone and tissue around teeth.
Scientists reprogram brain immune cells to fight Alzheimer’s
A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s models. The treatment reduced toxic plaque buildup and improved memory, raising hopes for a new therapeutic approach.
Analysis of 352 probiotic supplements finds mismatched microbes across marketed health benefits
Probiotic supplements found in drugstores nationwide contain an assortment of microbes sold for specific health purposes despite limited understanding of the microbes' connections to their marketed use, ...
Early-career scientists build national infrastructure to bridge science and policy
A new Special Report in the journal BioScience introduces the Scientist Network for Advancing Policy (SNAP), a student-led, nonpartisan, grassroots coalition founded in 2025 to empower early-career researchers ...
REV Ocean Begins First Operational Research Season With Ten-Mission Science Program
The missions cover seamount ecosystems off Brazil, in the Sargasso Sea, and across the Eastern Tropical Pacific—alongside Sargassum dynamics, mesophotic and deep-sea biodiversity, transboundary MPA networks, and the science-to-policy pipeline.
Defense Health Agency Outlines Joint Force Blood Therapy Strategy at National Forum
Medical logistics and prolonged field care in austere environments present significant challenges for the military health system. To address potential Large-Scale Combat Operations in remote locations across the globe, Defense Health Agency experts presented a strategy update for novel blood replacement therapies during the Strategic National Forum on Blood and Biotherapies, June 12, 2026, in Bethesda, Maryland.
MSU Texas grad pursues health care mission through biology
For Joshua De Waal, a childhood experience with his dad’s accident made one thing clear: quality health care can change lives—and he wants to be part of that change.
MSU Texas grad pursues health care mission through biology
For Joshua De Waal, a childhood experience with his dad’s accident made one thing clear: quality health care can change lives—and he wants to be part of that change.
Rubio lets Vance take the fall as Iran deal questions mount
A split over Iran between two top presidential contenders has burst into the open.
The surprising science of how fatherhood changes the brain
Studies suggest that, like mothers, fathers may undergo a shift in their biology in preparation for and in response to the responsibilities of parenthood.